University of Miami Sylvester Comprehensive Cancer Center

 

University of Miami's 2nd Biennial Miami Leukemia Symposium
Avatar

ALL Frontline Therapy for Young Adults: Building Upon a Successful “Backbone” With Addition of Targeted Agents to Eradicate MRD and Improve Tolerance/Decrease Toxicity

By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Wendy Stock
By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Wendy Stock
0 views
May 14, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
ALL Biology and Treatment
24:06
University of Miami's 2nd Biennial Miami Leukemia Symposium

ALL Frontline Therapy for Young Adults: Building Upon a Successful “…

Feat. W. Stock
20:50
University of Miami's 2nd Biennial Miami Leukemia Symposium

Relapsed/Refractory ALL: Both Inotuzumab and Blinatumomab Are Superi…

Feat. D. DeAngelo